I. Maestu

Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.

A. Carrato, C. García-Girón, R. Rosell, 2004, Clinical lung cancer.

FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer.

J. Aparicio, J. M. Vincent, C. Llorca, 2005, Clinical colorectal cancer.